Treating chronic lymphocytic leukemia with a combination of rituximab and alemtuzumab: a "successful couple," but are they still relevant together?
Leuk Lymphoma
.
2015 Feb;56(2):275-6.
doi: 10.3109/10428194.2014.946026.
Epub 2014 Aug 20.
Authors
Christian H Geisler
1
,
Tamar Tadmor
,
Aaron Polliack
Affiliation
1
Department of Hematology , Rigshospitalet, Copenhagen , Denmark.
PMID:
25065699
DOI:
10.3109/10428194.2014.946026
No abstract available
Publication types
Comment
MeSH terms
Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
Female
Humans
Leukemia, Lymphocytic, Chronic, B-Cell / drug therapy*
Male